Quoin Pharmaceuticals, Ltd. reports

Company location
Kfar Saba
Quoin Pharmaceuticals, Ltd. has filed 552 SEC EDGAR filings since 08 Apr 2016

SEC filing history

Showing 76-100 of 552 matching filings.

Per page
25
Current page
4
SCHEDULE 13G/A File 005-89873

SCHEDULE 13G/A filing

Filing date
15 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-277016

EFFECT filing

Filing date
03 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-277016

POS AM

Filing date
28 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-89873

SCHEDULE 13G filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-89873

SCHEDULE 13D/A filing

Filing date
28 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-89873

SCHEDULE 13D/A filing

Filing date
28 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D File 005-89873

SCHEDULE 13D filing

Filing date
02 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D File 005-89873

SCHEDULE 13D filing

Filing date
02 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Dec 2024
Reporting date
23 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Dec 2024
Reporting date
23 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Dec 2024
Reporting date
23 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .